Dendritic cells (DCs) are rare but ubiquitous antigen-presenting cells situated in lymphoid and nonlymphoid organs throughout the body. The study of DCs located in the liver has been restricted by their relative scarcity and the difficulty of their isolation. Because granulocyte-macrophage colony-stimulating factor (GM-CSF) is a critical growth factor for DCs in vitro, we postulated that it would expand hepatic DCs in vivo. We found that adenoviralmediated GM-CSF overexpression in normal mice increased the number of liver DCs 400-fold to more than 100 million cells. GM-CSF-recruited DCs were CD11c ؉ DEC205 ؊ and had high expression of major histocompatibility complex (MHC) class II, CD54, and CD80 but low CD40 and CD86 staining. Further maturation occurred after overnight culture. In addition to CD11c ؉ DEC205 ؊ DCs, a population of CD11c ؊ DEC205 low/؊ cells resembling DC progenitors described previously in normal mice was expanded as serum GM-CSF levels increased. GM-CSF-recruited CD11c D endritic cells (DCs) are rare, heterogeneous leukocytes that are primarily responsible for the capture of antigens in the periphery and subsequent presentation to immune effector cells. 1-3 Although there is a large and rapidly expanding body of data regarding the phenotype and function of murine bone marrowderived DCs and splenic DCs, our understanding of hepatic DCs is rudimentary. [4][5][6] This is due to the scarcity of hepatic DCs and the difficulty of isolating them from normal mice. Most of our knowledge emanates from using granulocyte-macrophage colony-stimulating factor (GM-CSF) to propagate liver DCs in vitro from DC progenitors contained within hepatic nonparenchymal cells (NPCs). 7,8 This approach is analogous to the method commonly used to produce DCs from bone marrow cells. 4 Hepatic DC progenitors have low expression of major histocompatibility complex (MHC) class II and the DC-restricted markers DEC205, CD11c, and 33D1 and produce only low levels of allostimulation in a mixed leukocyte reaction. 7 However, they can differentiate (i.e., gain CD11c and MHC class II expression) into immature DCs in vitro in the presence of GM-CSF. After additional culture on type-1 collagen, the immature liver DCs then become mature with increased surface costimulatory molecule expression and T-cell stimulatory capacity. 7 More recently, the phenotype of freshly isolated CD11c ϩ liver DCs has been described. Consistent with studies of hepatic DCs propagated from DC progenitors in vitro, it was shown that freshly isolated liver DCs were immature, with low MHC class II and costimulatory molecule (CD40, CD80, and CD86) expression. 9 The ability of freshly isolated liver DCs to stimulate T cells has not been well defined.